Perea-Romero, I. http://orcid.org/0000-0002-6402-4891
Blanco-Kelly, F.
Sanchez-Navarro, I.
Lorda-Sanchez, I.
Tahsin-Swafiri, S.
Avila-Fernandez, A.
Martin-Merida, I.
Trujillo-Tiebas, M. J.
Lopez-Rodriguez, R.
Rodriguez de Alba, M.
Iancu, I. F.
Romero, R.
Quinodoz, M.
Hakonarson, H.
Garcia-Sandova, Blanca
Minguez, P.
Corton, M.
Rivolta, C.
Ayuso, C. http://orcid.org/0000-0002-9242-7065
Funding for this research was provided by:
Instituto de Salud Carlos III (PI16/00425, PI19/00321, FI17/00192, CP16/00116, CPII17/00006)
Centro de Investigación Biomédica en Red Enfermedades Raras (06/07/0036)
IIS-FJD Biobank (PT13/0010/0012)
Comunidad de Madrid (B2017/BMD-3721, PEJ-17-AI/BMD7256)
European Regional Development Fund
Organización Nacional de Ciegos Españoles
Fundación Ramón Areces
Fundación Conchita Rábago
University Chair UAM-IIS-FJD of Genomic Medicine
Article History
Received: 23 April 2021
Accepted: 10 August 2021
First Online: 26 August 2021
Declarations
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest.
: This research has been reviewed and approved by the FJD Research Ethics Committee under approval number PIC172-20_FJD and it fulfils all the principles of the Declaration of Helsinki and its revisions.
: All patients, or their legal guardians when necessary, signed the written informed consent forms before entering the study.